{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:27:54Z","timestamp":1791149274579,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2008,9,9]],"date-time":"2008-09-09T00:00:00Z","timestamp":1220918400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1038\/ncpcardio1326","type":"journal-article","created":{"date-parts":[[2008,9,9]],"date-time":"2008-09-09T09:23:11Z","timestamp":1220952191000},"page":"730-737","source":"Crossref","is-referenced-by-count":51,"title":["APOA5 genetic variants are markers for classic hyperlipoproteinemia phenotypes and hypertriglyceridemia"],"prefix":"10.1038","volume":"5","author":[{"given":"Jian","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R","family":"Ban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke A","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim","family":"Yusuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murray W","family":"Huff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L","family":"Pollex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A","family":"Hegele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,9,9]]},"reference":[{"key":"BFncpcardio1326_CR1","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1161\/01.CIR.0000089506.12223.F1","volume":"108","author":"PW Wilson","year":"2003","unstructured":"Wilson PW and Grundy SM (2003) The metabolic syndrome: a practical guide to origins and treatment: Part II. Circulation 108: 1537\u20131540","journal-title":"Circulation"},{"key":"BFncpcardio1326_CR2","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1161\/CIRCULATIONAHA.106.637793","volume":"115","author":"N Sarwar","year":"2007","unstructured":"Sarwar N  et al. (2007) Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation 115: 450\u2013458","journal-title":"Circulation"},{"key":"BFncpcardio1326_CR3","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0140-6736(03)14234-1","volume":"362","author":"P Durrington","year":"2003","unstructured":"Durrington P (2003) Dyslipidaemia. Lancet 362: 717\u2013731","journal-title":"Lancet"},{"key":"BFncpcardio1326_CR4","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1503\/cmaj.060963","volume":"176","author":"G Yuan","year":"2007","unstructured":"Yuan G  et al. (2007) Hypertriglyceridemia: its etiology, effects and treatment. CMAJ 176: 1113\u20131120","journal-title":"CMAJ"},{"key":"BFncpcardio1326_CR5","first-page":"434","volume":"15","author":"DR MacLean","year":"1999","unstructured":"MacLean DR  et al. (1999) Plasma lipids and lipoprotein reference values, and the prevalence of dyslipoproteinemia in Canadian adults. Canadian Heart Health Surveys Research Group. Can J Cardiol 15: 434\u2013444","journal-title":"Can J Cardiol"},{"key":"BFncpcardio1326_CR6","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/00041433-200204000-00006","volume":"13","author":"PJ Talmud","year":"2002","unstructured":"Talmud PJ and Humphries SE (2002) Gene:environment interaction in lipid metabolism and effect on coronary heart disease risk. Curr Opin Lipidol 13: 149\u2013154","journal-title":"Curr Opin Lipidol"},{"key":"BFncpcardio1326_CR7","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1086\/513473","volume":"80","author":"GV Kryukov","year":"2007","unstructured":"Kryukov GV  et al. (2007) Most rare missense alleles are deleterious in humans: implications for complex disease and association studies. Am J Hum Genet 80: 727\u2013739","journal-title":"Am J Hum Genet"},{"key":"BFncpcardio1326_CR8","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1503\/cmaj.051313","volume":"174","author":"G Yuan","year":"2006","unstructured":"Yuan G  et al. (2006) Heterozygous familial hypercholesterolemia: an underrecognized cause of early cardiovascular disease. CMAJ 174: 1124\u20131129","journal-title":"CMAJ"},{"key":"BFncpcardio1326_CR9","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.7326\/0003-4819-120-12-199406150-00009","volume":"120","author":"CC Walden","year":"1994","unstructured":"Walden CC and Hegele RA (1994) Apolipoprotein E in hyperlipidemia. Ann Intern Med 120: 1026\u20131036","journal-title":"Ann Intern Med"},{"key":"BFncpcardio1326_CR10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1126\/science.1064852","volume":"294","author":"LA Pennacchio","year":"2001","unstructured":"Pennacchio LA  et al. (2001) An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294: 169\u2013173","journal-title":"Science"},{"key":"BFncpcardio1326_CR11","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1097\/01.mol.0000217892.00618.54","volume":"17","author":"S Calandra","year":"2006","unstructured":"Calandra S  et al. (2006) APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency. Curr Opin Lipidol 17: 122\u2013127","journal-title":"Curr Opin Lipidol"},{"key":"BFncpcardio1326_CR12","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.atherosclerosis.2006.12.010","volume":"194","author":"PJ Talmud","year":"2007","unstructured":"Talmud PJ (2007) Rare APOA5 mutations\u2014clinical consequences, metabolic and functional effects: an ENID review. Atherosclerosis 194: 287\u2013292","journal-title":"Atherosclerosis"},{"key":"BFncpcardio1326_CR13","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1093\/hmg\/11.24.3031","volume":"11","author":"LA Pennacchio","year":"2002","unstructured":"Pennacchio LA  et al. (2002) Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet 11: 3031\u20133038","journal-title":"Hum Mol Genet"},{"key":"BFncpcardio1326_CR14","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1093\/hmg\/11.24.3039","volume":"11","author":"PJ Talmud","year":"2002","unstructured":"Talmud PJ  et al. (2002) Relative contribution of variation within the APOC3\/A4\/A5 gene cluster in determining plasma triglycerides. Hum Mol Genet 11: 3039\u20133046","journal-title":"Hum Mol Genet"},{"key":"BFncpcardio1326_CR15","doi-asserted-by":"publisher","first-page":"28215","DOI":"10.1074\/jbc.M502144200","volume":"280","author":"PJ Talmud","year":"2005","unstructured":"Talmud PJ  et al. (2005) Determination of the functionality of common APOA5 polymorphisms. J Biol Chem 280: 28215\u201328220","journal-title":"J Biol Chem"},{"key":"BFncpcardio1326_CR16","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0140-6736(00)02502-2","volume":"356","author":"SS Anand","year":"2000","unstructured":"Anand SS  et al. (2000) Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet 356: 279\u2013284","journal-title":"Lancet"},{"key":"BFncpcardio1326_CR17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1161\/01.ATV.0000047460.27435.B8","volume":"23","author":"RA Hegele","year":"2003","unstructured":"Hegele RA  et al. (2003) Elevated serum C-reactive protein and free fatty acids among nondiabetic carriers of missense mutations in the gene encoding lamin A\/C (LMNA) with partial lipodystrophy. Arterioscler Thromb Vasc Biol 23: 111\u2013116","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFncpcardio1326_CR18","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1194\/jlr.D400030-JLR200","volume":"46","author":"J Wang","year":"2005","unstructured":"Wang J  et al. (2005) Multiplex ligation-dependent probe amplification of LDLR enhances molecular diagnosis of familial hypercholesterolemia. J Lipid Res 46: 366\u2013372","journal-title":"J Lipid Res"},{"key":"BFncpcardio1326_CR19","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/humu.1205","volume":"18","author":"J Wang","year":"2001","unstructured":"Wang J  et al. (2001) Low density lipoprotein receptor (LDLR) gene mutations in Canadian subjects with familial hypercholesterolemia, but not of French descent. Hum Mutat 18: 359","journal-title":"Hum Mutat"},{"key":"BFncpcardio1326_CR20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1161\/01.ATV.0000099881.83261.D4","volume":"24","author":"S Eichenbaum-Voline","year":"2004","unstructured":"Eichenbaum-Voline S  et al. (2004) Linkage and association between distinct variants of the APOA1\/C3\/A4\/A5 gene cluster and familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 24: 167\u2013174","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFncpcardio1326_CR21","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/0002-9149(92)90550-I","volume":"70","author":"G Assmann","year":"1992","unstructured":"Assmann G and Schulte H (1992) Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Munster study. Am J Cardiol 70: 733\u2013737","journal-title":"Am J Cardiol"},{"key":"BFncpcardio1326_CR22","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1161\/01.ATV.14.8.1233","volume":"14","author":"P Cullen","year":"1994","unstructured":"Cullen P  et al. (1994) Complex segregation analysis provides evidence for a major gene acting on serum triglyceride levels in 55 British families with familial combined hyperlipidemia. Arterioscler Thromb 14: 1233\u20131249","journal-title":"Arterioscler Thromb"},{"key":"BFncpcardio1326_CR23","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1172\/JCI107332","volume":"52","author":"JL Goldstein","year":"1973","unstructured":"Goldstein JL  et al. (1973) Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 52: 1544\u20131568","journal-title":"J Clin Invest"},{"key":"BFncpcardio1326_CR24","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1399-0004.2005.00510.x","volume":"68","author":"D Evans","year":"2005","unstructured":"Evans D  et al. (2005) Polymorphisms in the apolipoprotein A5 (APOA5) gene and type III hyperlipidemia. Clin Genet 68: 369\u2013372","journal-title":"Clin Genet"},{"key":"BFncpcardio1326_CR25","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1161\/01.ATV.17.9.1707","volume":"17","author":"SC Whitman","year":"1997","unstructured":"Whitman SC  et al. (1997) Uptake of type III hypertriglyceridemic VLDL by macrophages is enhanced by oxidation, especially after remnant formation. Arterioscler Thromb Vasc Biol 17: 1707\u20131715","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFncpcardio1326_CR26","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","volume":"215","author":"SF Altschul","year":"1990","unstructured":"Altschul SF  et al. (1990) Basic local alignment search tool. J Mol Biol 215: 403\u2013410","journal-title":"J Mol Biol"},{"key":"BFncpcardio1326_CR27","unstructured":"NCBI Map Viewer [\n                    http:\/\/www.ncbi.nlm.nih.gov\/mapview\/map_search.cgi?taxid=9606\n                    \n                  ] (accessed 19 July 2008)"},{"key":"BFncpcardio1326_CR28","unstructured":"Applied Biosystems [\n                    http:\/\/www.appliedbiosystems.com\/support\/software\/\n                    \n                  ]"},{"key":"BFncpcardio1326_CR29","unstructured":"SAS Institute Inc [\n                    http:\/\/www.sas.com\/technologies\/analytics\/statistics\/stat\/index.html\n                    \n                  ]"},{"key":"BFncpcardio1326_CR30","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1086\/379378","volume":"73","author":"M Stephens","year":"2003","unstructured":"Stephens M and Donnelly P (2003) A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73: 1162\u20131169","journal-title":"Am J Hum Genet"},{"key":"BFncpcardio1326_CR31","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.ygeno.2007.08.003","volume":"90","author":"N Ahituv","year":"2007","unstructured":"Ahituv N  et al. (2007) In vivo characterization of human APOA5 haplotypes. Genomics 90: 674\u2013679","journal-title":"Genomics"},{"key":"BFncpcardio1326_CR32","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/349161a0","volume":"349","author":"AP Wojciechowski","year":"1991","unstructured":"Wojciechowski AP  et al. (1991) Familial combined hyperlipidaemia linked to the apolipoprotein AI-CII-AIV gene cluster on chromosome 11q23-q24. Nature 349: 161\u2013164","journal-title":"Nature"},{"key":"BFncpcardio1326_CR33","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1161\/01.ATV.11.5.1137","volume":"11","author":"PN Hopkins","year":"1991","unstructured":"Hopkins PN  et al. (1991) Type III dyslipoproteinemia in patients heterozygous for familial hypercholesterolemia and apolipoprotein E2. Evidence for a gene-gene interaction. Arterioscler Thromb 11: 1137\u20131146","journal-title":"Arterioscler Thromb"},{"key":"BFncpcardio1326_CR34","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S0021-9150(99)00330-5","volume":"149","author":"G Moennig","year":"2000","unstructured":"Moennig G  et al. (2000) Detection of missense mutations in the genes for lipoprotein lipase and hepatic triglyceride lipase in patients with dyslipidemia undergoing coronary angiography. Atherosclerosis 149: 395\u2013401","journal-title":"Atherosclerosis"},{"key":"BFncpcardio1326_CR35","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1161\/01.ATV.15.10.1695","volume":"15","author":"H Zhang","year":"1995","unstructured":"Zhang H  et al. (1995) Patients with apoE3 deficiency (E2\/2, E3\/2, and E4\/2) who manifest with hyperlipidemia have increased frequency of an Asn 291\u2192Ser mutation in the human LPL gene. Arterioscler Thromb Vasc Biol 15: 1695\u20131703","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFncpcardio1326_CR36","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1161\/01.ATV.14.11.1695","volume":"14","author":"WA Groenewegen","year":"1994","unstructured":"Groenewegen WA  et al. (1994) Dysbetalipoproteinemia in a kindred with hypobetalipoproteinemia due to mutations in the genes for ApoB (ApoB-70.5) and ApoE (ApoE2). Arterioscler Thromb 14: 1695\u20131704","journal-title":"Arterioscler Thromb"},{"key":"BFncpcardio1326_CR37","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1373\/clinchem.2004.037689","volume":"50","author":"JR Schaefer","year":"2004","unstructured":"Schaefer JR  et al. (2004) Hyperlipidemia in patients with apolipoprotein E 2\/2 phenotype: apolipoprotein A5 S19W mutation as a cofactor. Clin Chem 50: 2214","journal-title":"Clin Chem"},{"key":"BFncpcardio1326_CR38","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1373\/clinchem.2005.048439","volume":"51","author":"JA Hubacek","year":"2005","unstructured":"Hubacek JA  et al. (2005) Hypertriglyceridemia: interaction between APOE and APOAV variants. Clin Chem 51: 1311\u20131313","journal-title":"Clin Chem"},{"key":"BFncpcardio1326_CR39","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1373\/clinchem.2006.070318","volume":"52","author":"JM Mart\u00edn-Campos","year":"2006","unstructured":"Mart\u00edn-Campos JM  et al. (2006) Apolipoprotein A5 S19W may play a role in dysbetalipoproteinemia in patients with the Apo E2\/E2 genotype. Clin Chem 52: 1974\u20131975","journal-title":"Clin Chem"},{"key":"BFncpcardio1326_CR40","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.atherosclerosis.2006.05.030","volume":"193","author":"P Henneman","year":"2007","unstructured":"Henneman P  et al. (2007) Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphism. Atherosclerosis 193: 129\u2013134","journal-title":"Atherosclerosis"},{"key":"BFncpcardio1326_CR41","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.bbadis.2006.10.012","volume":"1772","author":"GM van der Vleuten","year":"2007","unstructured":"van der Vleuten GM  et al. (2007) Haplotype analyses of the APOA5 gene in patients with familial combined hyperlipidemia. Biochim Biophys Acta 1772: 81\u201388","journal-title":"Biochim Biophys Acta"},{"key":"BFncpcardio1326_CR42","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1161\/ATVBAHA.107.150680","volume":"27","author":"J Wang","year":"2007","unstructured":"Wang J  et al. (2007) Resequencing genomic DNA of patients with severe hypertriglyceridemia (MIM 144650). Arterioscler Thromb Vasc Biol 27: 2450\u20132455","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Nature Clinical Practice Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpcardio1326.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpcardio1326","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpcardio1326.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T19:46:06Z","timestamp":1684439166000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpcardio1326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,9]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["BFncpcardio1326"],"URL":"https:\/\/doi.org\/10.1038\/ncpcardio1326","relation":{},"ISSN":["1743-4297","1743-4300"],"issn-type":[{"value":"1743-4297","type":"print"},{"value":"1743-4300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,9]]}}}